The HIV care cascade: A systematic review of data sources, methodology and comparability

Journal of the International AIDS Society

Volumn 18, Issue 1, 2015, Pages

  Medland, Nicholas A ^a,b   McMahon, James H ^c   Chow, Eric P F ^a,b   Elliott, Julian H ^c   Hoy, Jennifer F ^c   Fairley, Christopher K ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MELBOURNE SEXUAL HEALTH CENTRE   (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

Antiretroviral therapy; Cascade; HIV; HIV care cascade; HIV treatment cascade.; Population based data; Treatment as prevention; Treatment coverage

Indexed keywords

ARTICLE; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; DIAGNOSTIC PROCEDURE; HEALTH CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MANDATORY REPORTING; METHODOLOGY; PRIORITY JOURNAL; SYSTEMATIC REVIEW; VIRAL LOAD TESTING; HIV INFECTIONS; IMMUNOLOGY; INFORMATION RETRIEVAL; VIROLOGY; VIRUS LOAD;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; INFORMATION STORAGE AND RETRIEVAL; VIRAL LOAD;

EID: 84959359296     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.18.1.20634     Document Type: Article

References (44)

1. Sidibe M, Zuniga JM, Montaner J. Leveraging HIV treatment to end AIDS, stop new HIV infections, and avoid the cost of inaction. Clin Infect Dis. 2014;59(Suppl 1):S3-6.
2. UNAIDS. 90-90-90 an ambitious treatment target to help end the HIV epidemic. Geneva: UNAIDS; 2014.
3. Obama B. Executive order-HIV care continuum initiative 2013 [Internet]. [cited 2015 Feb 15]. Available from: http://www.whitehouse.gov/the-pressoffice/2013/07/15/executive-order-hiv-care-continuum-initiative
4. NSW Health. NSW HIV Strategy 2012-2015 2014 Data report [Internet]. [cited 2015 Nov 16]. Available from: http://www.health.nsw.gov.au/endinghiv/Documents/annual-2014-hiv-data-report.pdf
5. TEMPRANO Study Group. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373:808-22.
6. INSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373:795-807.
7. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493-505.
8. Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339(6122):966-71.
9. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-And-Treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793-800.
10. Nachega JB, Uthman OA, del Rio C, Mugavero MJ, Rees H, Mills EJ. Addressing the Achilles' heel in the HIV care continuum for the success of a test-And-Treat strategy to achieve an AIDS-free generation. Clin Infect Dis. 2014;59(Suppl 1):S21-7.
11. Raymond A, Hill A, Pozniak A. Large disparities in HIV treatment cascades between eight European and high-income countries-Analysis of break points. J Int AIDS Soc. 2014;17(4 Suppl 3):19507, doi: http://dx.doi.org/10.7448/IAS. 17.4.19507
12. Medland NA, Fairley CK, Elliott JH, Chow EPF, McMahon JH. The cascade of HIV diagnosis, care and treatment: A systematic review of methodology and comparability. PROSPERO 2015: CRD42015016718. Available from: http://www.crd.york.ac.uk/PROSPERO/display-record.asp?ID=CRD42015016718
13. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-Analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.
14. OECD Member Countries [Internet]. [cited 2015 May 15]. Available from: http://data.worldbank.org/about/country-And-lending-groups-OECD-members
15. Cohen SM, Van Handel MM, Branson BM, Blair JM, Hall HI, Hu X, et al. Vital signs: HIV prevention through care and treatment-United States. MMWR Morb Mortal Wkly Rep. 2011;60(47):1618-23.
16. Hall HI, Frazier EL, Rhodes P, Holtgrave DR, Furlow-Parmley C, Tang T, et al. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med. 2013;173(14):1337-44.
17. Bradley H, Hall HI, Wolitski RJ, Van Handel MM, Stone AE, LaFlam M, et al. Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV-United States, 2011. MMWR Morb Mortal Wkly Rep. 2014;63(47):1113-7.
18. Singh S, Bradley H, Hu X, Skarbinski J, Hall HI, Lansky A. Men living with diagnosed HIV who have sex with men: progress along the continuum of HIV care-United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63(38):829-33.
19. Whiteside YO, Cohen SM, Bradley H, Skarbinski J, Hall HI, Lansky A, et al. Progress along the continuum of HIV care among blacks with diagnosed HIV-United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63(5):85-9.
20. Gant Z, Bradley H, Hu X, Skarbinski J, Hall HI, Lansky A. Hispanics or Latinos living with diagnosed HIV: progress along the continuum of HIV care-United States, 2010. MMWR Morb Mortal Wkly Rep. 2014;63(40):886-90.
21. Gray KM, Cohen SM, Hu X, Li J, Mermin J, Hall HI. Jurisdiction level differences in HIV diagnosis, retention in care, and viral suppression in the United States. J Acquir Immune Defic Syndr. 2014;65(2):129-32.
22. Torian LV, Xia Q, Wiewel EW. Retention in care and viral suppression among persons living with HIV/AIDS in New York City, 2006-2010. Am J Public Health. 2014;104(9):e24-9.
23. Dombrowski JC, Buskin SE, Bennett A, Thiede H, Golden MR. Use of multiple data sources and individual case investigation to refine surveillancebased estimates of the HIV care continuum. J Acquir Immune Defic Syndr. 2014;67(3):323-30.
24. Nosyk B, Montaner JS, Colley G, Lima VD, Chan K, Heath K, et al. The cascade of HIV care in British Columbia, Canada, 1996-2011: A populationbased retrospective cohort study. Lancet Infect Dis. 2014;14(1):40-9.
25. Helleberg M, Haggblom A, Sonnerborg A, Obel N. HIV care in the Swedish-Danish HIV cohort 1995-2010, closing the gaps. PLoS One. 2013;8(8):e72257.
26. Chkhartishvili N, Sharavdze L, Chokoshvili O, DeHovitz JA, del Rio C, Tsertsvadze T. The cascade of care in the Eastern European country of Georgia. HIV Med. 2015;16(1):62-6.
27. The Kirby Institute. HIV, viral heptatitis and sexually transmissive infection in Australia Annual Surveillance Report 2014 HIV supplement. Sydney, Australia: The Kirby Institute, UNSW; 2014.
28. CDC. HIV surveillance-United States, 1981-2008. MMWR Morb Mortal Wkly Rep. 2011;60(21):689-93.
29. Marks G, Gardner LI, Craw J, Crepaz N. Entry and retention in medical care among HIV-diagnosed persons: A meta-Analysis. AIDS. 2010;24(17):2665-78.
30. Torian LV, Wiewel EW. Continuity of HIV-related medical care, New York City, 2005-2009: do patients who initiate care stay in care? AIDS Patient Care STDS. 2011;25(2):79-88.
31. Hall HI, Mahle KC, Tang T, Li J, Johnson AS, Shouse L. Retention in care of HIV-infected adults and adolescents in 13 U.S. areas. National HIV Prevention Conference; 2011 Aug 14-17, Atlanta, GA; 2011.
32. Tripathi A, Youmans E, Gibson JJ, Duffus WA. The impact of retention in early HIV medical care on viro-immunological parameters and survival: A statewide study. AIDS Res Hum Retroviruses. 2011;27(7):751-8.
33. Centers for Disease Control and Prevention. Diagnoses of HIV infection and AIDS in the United States and dependent areas, 2010. Atlanta, GA: US Dept of Health and Human Services, CDC; 2012.
34. Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300(5):520-9.
35. CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data-United States and 6 dependent areas-2012. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2014.
36. Chen M, Rhodes PH, Hall IH, Kilmarx PH, Branson BM, Valleroy LA. Prevalence of undiagnosed HIV infection among persons aged-/-13 years-National HIV Surveillance System, United States, 2005-2008. MMWR Morb Mortal Wkly Rep. 2012;61(Suppl):57-64.
37. Boulos D, Yan P, Remis RS, Archibald CP. Estimates of HIV prevalence and incidence in Canada, 2005. Can Commun Dis Rep. 2006;32(15):165-74.
38. Jansson J, Kerr CC, Wilson DP. Predicting the population impact of increased HIV testing and treatment in Australia. Sex Health. 2014;11(2):146-54.
39. Jansson J, Kerr CC, Mallitt K, Wu J, Gray RT, Wilson DP. Inferring HIV incidence from case surveillance with CD4 counts. In review. AIDS. 2015;29:1517-25.
40. The Kirby Institute. Australian HIV Observational Database Annual Report. Sydney, NSW: The Kirby Institute, The University of New South Wales; 2013.
41. UNAIDS. Spectrum EPP 2013 [Internet]. [2015 March 24]. Available from: http://www.unaids.org/en/dataanalysis/datatools/spectrumepp2013
42. Dombrowski JC, Kent JB, Buskin SE, Stekler JD, Golden MR. Populationbased metrics for the timing of HIV diagnosis, engagement in HIV care, and virologic suppression. AIDS. 2012;26(1):77-86.
43. Law MG, McDonald AM, Kaldor JM. Estimation of cumulative HIV incidence in Australia, based on national case reporting. Aust NZJ Public Health. 1996;20(2):215-7.
44. Buskin SE, Kent JB, Dombrowski JC, Golden MR. Migration distorts surveillance estimates of engagement in care: results of public health investigations of persons who appear to be out of HIV care. Sex Transm Dis. 2014; 41(1):35-40.